Prospects for the use of deep brain stimulation in the treatment of Parkinson's disease in Ukraine

K.R. Kostiuk; A.O. Lisianyi; Yu.M. Medvediev; A.O. Popov; V.V. Cheburakhin; V.M. Buniakin; D.A.  Tevzadze

doi:10.26641/2307-0404.2024.4.319368

Authors

K.R. Kostiuk State Institution “Romodanov Neurosurgery Institute” National Academy of Medical Sciences of Ukraine, Platona Maiborody str., 32, Kyiv, 04050, Ukraine https://orcid.org/0000-0002-3277-5025
A.O. Lisianyi State Institution “Romodanov Neurosurgery Institute” National Academy of Medical Sciences of Ukraine, Platona Maiborody str., 32, Kyiv, 04050, Ukraine https://orcid.org/0000-0002-4245-2377
Yu.M. Medvediev State Institution “Romodanov Neurosurgery Institute” National Academy of Medical Sciences of Ukraine, Platona Maiborody str., 32, Kyiv, 04050, Ukraine https://orcid.org/0000-0002-9999-8813
A.O. Popov State Institution “Romodanov Neurosurgery Institute” National Academy of Medical Sciences of Ukraine, Platona Maiborody str., 32, Kyiv, 04050, Ukraine https://orcid.org/0000-0001-9741-2711
V.V. Cheburakhin State Institution “Romodanov Neurosurgery Institute” National Academy of Medical Sciences of Ukraine, Platona Maiborody str., 32, Kyiv, 04050, Ukraine https://orcid.org/0000-0002-6820-5673
V.M. Buniakin State Institution “Romodanov Neurosurgery Institute” National Academy of Medical Sciences of Ukraine, Platona Maiborody str., 32, Kyiv, 04050, Ukraine https://orcid.org/0000-0001-8643-1693
D.A. Tevzadze State Institution “Romodanov Neurosurgery Institute” National Academy of Medical Sciences of Ukraine, Platona Maiborody str., 32, Kyiv, 04050, Ukraine https://orcid.org/0000-0002-5298-2179

DOI:

https://doi.org/10.26641/2307-0404.2024.4.319368

Keywords:

Parkinson's disease, deep brain stimulation, radiofrequency destruction

Abstract

Aim of the study – evaluation of the results of various methods of surgical treatment of Parkinson's disease depending on the clinical manifestations and stage of the disease. The study included 566 patients with Parkinson's disease (PD), comprising 201 (35.5%) women and 365 (64.5%) men, aged 30 to 79 years (mean age 52.9±8.8 years). Radiofrequency (RF) destruction of the subcortical nuclei was performed on 522 patients: 392 underwent unilateral thalamotomy, 50 underwent bilateral thalamotomy, 36 underwent unilateral pallidotomy, 2 underwent bilateral pallidotomy, 30 underwent thalamotomy combined with contralateral pallidotomy, and 12 underwent thalamotomy combined with contralateral subthalamic nucleus (STN) destruction. Additionally, neurostimulation surgery was performed on 37 patients, and combined surgical interventions (stereotactic RF destruction and deep brain stimulation (DBS) system implantation) were performed on 7 patients. Postoperative follow-up ranged from 1 to 16 years (mean follow-up 5.2±0.9 years). One year after RF unilateral thalamotomy, tremor abolishing or significant regression was observed in 374 out of 392 patients (95.4%). Rigidity regressed in 278 out of 314 patients (88.5%) who had it before operation. Postoperative complications from unilateral thalamotomy occurred in 18 patients (4.6%). Following staged bilateral thalamotomy, tremor regression was observed in 48 out of 50 patients (96.0%) and motor fluctuations (MF) regressed in 15 out of 28 patients (53.6%). The rate of surgical complications was higher after bilateral thalamotomy (8.0%) compared to unilateral thalamotomy. After unilateral and staged bilateral pallidotomy, tremor and rigidity regression were achieved in more than two-thirds of operated patients, and levodopa-induced dyskinesias (LID) stopped in over 80% of cases. The best outcomes for alleviating motor symptoms were observed in patients who underwent DBS treatment. Staged bilateral RF ablation can be considered an alternative surgical treatment for a highly selected group of patients.

References

İbrahimoğlu Ö, Mersin S, Akyol E. The Experiences of Patients with Deep Brain Stimulation in Parkin-son’s Disease: Challenges, Expectations, and Accompli-shments. Acta Medica Acad. 2020 Apr;49(1):36-43. doi: https://doi.org/10.5644/ama2006-124.281

Hariz M, Blomstedt P. Deep brain stimulation for Parkinson’s disease. J Intern Med. 2022 Nov;292(5):764-78. doi: https://doi.org/10.1111/joim.13541

Doshi P, Das D. Deep Brain Stimulation for Parkinson’s Disease: Currents Status and Emerging Concepts. Neurol India. 2020 Nov;68(Suppl):S179-86. doi: https://doi.org/10.4103/0028-3886.302466

Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord Off J Mov Disord Soc. 2014 Nov;29(13):1583-90. doi: https://doi.org/10.1002/mds.25945

Rong S, Xu G, Liu B, Sun Y, Snetselaar LG, Wallace RB, et al. Trends in Mortality From Parkinson Disease in the United States, 1999-2019. Neurology. 2021 Nov 16;97(20):e1986-93. doi: https://doi.org/10.1212/WNL.0000000000012826

Tarakad A, Jankovic J. Diagnosis and Manage-ment of Parkinson’s Disease. Semin Neurol. 2017 Apr;37(2):118-26. doi: https://doi.org/10.1055/s-0037-1601888

Elbaz A, Carcaillon L, Kab S, Moisan F. Epidemiology of Parkinson’s disease. Rev Neurol (Paris). 2016 Jan;172(1):14-26. doi: https://doi.org/10.1016/j.neurol.2015.09.012

Trufanov EO, Golovchenko YuI, Slobodin TM. [Epidemiology of Parkinson's disease in Ukraine]. [Inter-net]. International Neurological Journal. 2012 [cited 2024 Mar 15];7(53). Ukrainian. Available from: http://www.mif-ua.com/archive/issue-34116/

Krauss JK, Fernandes FW. Svennilson’s Publication on Pallidotomy for Parkinsonism in 1960: A Most Influential Paper in the Field. Mov Disord Clin Pract. 2022 Feb;9(2):173. doi: https://doi.org/10.1002/mdc3.13370

Krauss JK, Lipsman N, Aziz T, Boutet A, Brown P, Chang JW, et al. Technology of deep brain stimulation: current status and future directions. Nat Rev Neurol. 2021 Feb;17(2):75-87. doi: https://doi.org/10.1038/s41582-020-00426-z

Chou L, Hurtig I. Clinical manifestations of Par-kinson disease – UpToDate [Internet]. Available from: https://www.uptodate.com/contents/clinical-manifestations-of-parkinson-disease?topicRef=4906&source=see_link doi:

Zozulya YuP, Laponogov OO, Tsimbalyuk VI, Kostyuk KR. [Modern aspects of functional neurosurgery]. The art of Healing. 2004;5(011):4-7. Ukrainian.

Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol. 1987;50(1-6):344-6. doi: https://doi.org/10.1159/000100803

Obeso JA, Olanow CW, Rodriguez-Oroz MC, Krack P, Kumar R, Lang AE. Deepbrain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med. 2001 Sep 27;345(13):956-63. doi: https://doi.org/10.1056/NEJMoa000827

Kostyuk KR, Popov AO, Medvedev YuM, Zinke-vich YaP, Shevelyov MM, Dichko SM. [The first expe-rience of using deep brain stimulation in the treatment of Parkinson's disease in Ukraine]. Ukrainian Neurological Journal. 2013;(4):36-43. Ukrainian.

Kostyuk KR, Vasylov NS, Lomadze VL. [Experience of using deep brain stimulation in patients with Parkinson's disease with accompanying psychoneuro-logical disorders]. International Journal of Neurology. 2018;(5):42-7. Ukrainian. doi: https://doi.org/10.22141/2224-0713.5.99.2018.142964

Follett KA, Weaver FM, Stern M, Hur K, Har-ris CL, Luo P, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2010 Jun 3;362(22):2077-91. doi: https://doi.org/10.1056/NEJMoa0907083

Horisawa S, Kohara K, Nonaka T, Fukui A, Mochizuki T, Iijima M, et al. Unilateral pallidothalamic tractotomy at Forel’s field H1 for cervical dystonia. Ann Clin Transl Neurol. 2022 Apr;9(4):478-87. doi: https://doi.org/10.1002/acn3.51532

Manninen PH, Apichatibutra N. Anesthesia for Functional Neurosurgery In: AM Lozano, PL Gilden¬berg, RR Tasker, eds. Textbook of Stereotactic and Functional Neurosurgery. Berlin Heidelberg: Springer‐Verlag; 2009. р. 1331-48.

doi: https://doi.org/10.1007/978-3-540-69960-6_80

Rotter JG. Cosgrove R: Parkinson’s Disease: Lesions. In: Pouratian N, Sheth SA, eds. Stereotactic and Functional Neurosurgery. Switzerland: Springer Nature AG; 2020. р. 271-87.

doi: https://doi.org/10.1007/978-3-030-34906-6_19

Frey J, Cagle J, Johnson KA, et al. Past, Present, and Future of Deep Brain Stimulation: Hardware, Soft-ware, Imaging, Physiology and Novel Approaches. Frontiers in Neurology. 2022 Mar;13:1-20. doi: https://doi.org/10.3389/fneur.2022.825178

Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-Sponsored Revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimentric Testing Results. Movement Disorders. 2008;23(15):2129-70. doi: https://doi.org/10.1002/mds.22340

Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force Report on the Hoehn and Yahr Staging Scale: Status and Recommendations. The Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. Movement Disorders. 2004;19(9):1020-8. doi: https://doi.org/10.1002/mds.20213

Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;12(3):189-98. doi: https://doi.org/10.1016/0022-3956(75)90026-6

Schwab RS, England AC. Projection techniques for evaluating surgery in Parkinson's Disease. In: Billin-gham FH, Donaldson MC, eds. Third Symposium on Par-kinson's Disease. Royal College of Surgeons in Edinburgh, Livingstone Ltd; 1969. р. 152-7.

Mintzer OP, Voronenko YuV, Vlasov VV. [Processing of clinical and experimental data in medicine: training manual]. Kyiv: Vyshcha Shkola; 2003. 350 p. Ukrainian.

Kuusimäki T, Korpela J, Pekkonen E, Martikainen MH, Antonini A, Kaasinen V. Deep brain stimu-lation for monogenic Parkinson’s disease: a systematic review. J Neurol. 2020 Apr;267(4):883-97. doi: https://doi.org/10.1007/s00415-019-09181-8

Fabbri M, Zibetti M, Rizzone MG, Giannini G, Borellini L, Stefani A, et al. Should We Consider Deep Brain Stimulation Discontinuation in Late-Stage Par-kinson’s Disease? Mov Disord Off J Mov Disord Soc. 2020 Aug;35(8):1379-87. doi: https://doi.org/10.1002/mds.28091

Palmer AD, Charney S, Pietrowski J, Anderson S, Britton D, Bryans L, et al. Dysphagia in Parkinson’s di-sease patients prior to deep brain stimulation: Is screening accurate? Clin Neurol Neurosurg. 2021 Apr;203:106587. doi: https://doi.org/10.1016/j.clineuro.2021.106587

Bucur M, Papagno C. Deep Brain Stimulation in Parkinson Disease: A Meta-analysis of the Long-term Neuropsychological Outcomes. Neuropsychol Rev. 2023 Jun;33(2):307-46. doi: https://doi.org/10.1007/s11065-022-09540-9

Cartmill T, Skvarc D, Bittar R, McGillivray J, Berk M, Byrne LK. Deep Brain Stimulation of the Sub-thalamic Nucleus in Parkinson’s Disease: A Meta-Analysis of Mood Effects. Neuropsychol Rev. 2021 Sep;31(3):385-401. doi: https://doi.org/10.1007/s11065-020-09467-z

Brezovar S, Pažek L, Kavčič M, Georgiev D, Trošt M, Flisar D. Personality Changes After Subthalamic Nucleus Stimulation in Parkinson’s Disease. J Park Dis. 2022;12(4):1231-40.

doi: https://doi.org/10.3233/JPD-212879

Kennis M, Hale EW, Hemendinger E, Davis R, Ojemann SG, Strom L, et al. Suicide in Deep Brain Stimulation for Parkinson’s Disease: A Retrospective Case-Control Study. J Park Dis. 2023 May;13(3):415-9. doi: https://doi.org/10.3233/JPD-225049

Guo X, Feng C, Pu J, Jiang H, Zhu Z, Zheng Z, et al. Deep Brain Stimulation for Advanced Parkinson Disease in Developing Countries: A Cost-Effectiveness Study From China. Neurosurgery. 2023 Apr;92(4):812-9. doi: https://doi.org/10.1227/neu.0000000000002274

Hacker M, Cannard G, Turchan M, Meystedt J, Davis T, Phibbs F, et al. Early subthalamic nucleus deep brain stimulation in Parkinson’s disease reduces long-term medi¬cation costs. Clin Neurol Neurosurg. 2021 Nov;210:106976. doi: https://doi.org/10.1016/j.clineuro.2021.106976

Campbell MC, Myers PS, Weigand AJ, Fos¬ter ER, Cairns NJ, Jackson JJ, et al. Parkinson disease clinical subtypes: key features & clinical milestones. Ann Clin Transl Neurol. 2020 Aug;7(8):1272-83. doi: https://doi.org/10.1002/acn3.51102

Lin C, Ridder MC, Sah P. The PPN and motor control: Preclinical studies to deep brain stimulation for Parkinson’s disease. Front Neural Circuits. 2023;17:1095441. doi: https://doi.org/10.3389/fncir.2023.1095441

Rammo RA, Ozinga SJ, White A, Nagel SJ, Machado AG, Pallavaram S, et al. Directional Stimu-lation in Parkinson’s Disease and Essential Tremor: The Cleveland Clinic Experience. Neuromodulation J Int Neuromodulation Soc. 2022 Aug;25(6):829-35. doi: https://doi.org/10.1111/ner.13374

Ramanathan PV, Salas-Vega S, Shenai MB. Di-rectional Deep Brain Stimulation-A Step in the Right Direction? A Systematic Review of the Clinical and Therapeutic Efficacy of Directional Deep Brain Stimula-tion in Parkinson Disease. World Neurosurg. 2023 Feb;170:54-63.e1. doi: https://doi.org/10.1016/j.wneu.2022.11.085

Wang S, Zhu G, Shi L, Zhang C, Wu B, Yang A, et al. Closed-Loop Adaptive Deep Brain Stimulation in Parkinson’s Disease: Procedures to Achieve It and Future Perspectives. J Park Dis. 2023 Jun;13(4):453-71. doi: https://doi.org/10.3233/JPD-225053

Little S, Brown P. Debugging Adaptive Deep Brain Stimulation for Parkinson’s Disease. Mov Di-sord Off J Mov Disord Soc. 2020 Apr;35(4):555-61. doi: https://doi.org/10.1002/mds.27996

Boutet A, Madhavan R, Elias GJB, Joel SE, Gra-mer R, Ranjan M, et al. Predicting optimal deep brain stimulation parameters for Parkinson’s disease using functional MRI and machine learning. Nat Commun. 2021 Dec;12(1):1-13.

doi: https://doi.org/10.1038/s41467-021-23311-9

Hacker M, Cannard G, Turchan M, Meystedt J, Davis T, Phibbs F, et al. Early subthalamic nucleus deep brain stimulation in Parkinson’s disease reduces long-term medication costs. Clin Neurol Neurosurg. 2021 Nov;210:106976. doi: https://doi.org/10.1016/j.clineuro.2021.106976

Spindler P, Alzoobi Y, Kühn AA, Faust K, Schneider GH, Vajkoczy P. Deep brain stimulation for Parkinson’s disease-related postural abnormalities: a systematic review and meta-analysis. Neurosurg Rev. 2022 Oct;45(5):3083-92. doi: https://doi.org/10.1007/s10143-022-01830-3

Mahlknecht P, Foltynie T, Limousin P, Poewe W. How Does Deep Brain Stimulation Change the Course of Parkinson’s Disease? Mov Disord Off J Mov Disord Soc. 2022 Aug;37(8):1581-92. doi: https://doi.org/10.1002/mds.29052